Insys Therapeutics Inc (INSYQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2009 | 12-2008 | |
| Sales | 99,289 | 15,476 | 0 | 0 | 0 |
| Cost of Goods | 12,665 | 7,627 | N/A | N/A | N/A |
| Gross Profit | 86,624 | 7,849 | N/A | N/A | N/A |
| Operating Expenses | 54,730 | 31,916 | 17,373 | 6,500 | 9,130 |
| Operating Income | 32,559 | -23,440 | -17,373 | -6,500 | -9,130 |
| Interest Expense | 950 | 2,684 | 1,963 | 150 | 0 |
| Other Income | -32 | 1,746 | -25 | -810 | 920 |
| Pre-tax Income | 31,577 | -24,378 | -19,361 | -7,460 | -8,210 |
| Income Tax | -8,800 | 0 | N/A | N/A | N/A |
| Net Income Continuous | 40,377 | -24,378 | -19,361 | -6,444 | -8,218 |
| Net Income | $40,377 | $-24,378 | $-19,361 | $-7,460 | $-8,210 |
| EPS Basic Total Ops | 0.78 | -0.87 | -0.69 | -5.28 | -5.89 |
| EPS Basic Continuous Ops | 0.78 | -0.87 | -0.01 | -4.60 | -5.86 |
| EPS Diluted Total Ops | 0.70 | -0.87 | -0.69 | -5.28 | -5.89 |
| EPS Diluted Continuous Ops | 0.70 | -0.87 | -0.01 | -4.60 | -5.86 |
| EPS Diluted Before Non-Recurring Items | 0.58 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $34,347 | $-21,778 | $-15,988 | $-6,500 | $-9,130 |